#$%^&*AU2013201090B220140206.pdf#####ABSTRACT The present application provides methods of treating HIV-associated neurological disease (HAND) comprising reducing proviral load of a subject with said disease by administering to the subject a therapeutically effective amount of a polyanine analog whereby reducing the proviral load in the subject, wherein the subject does not have AIDS-associated dementia or AIDS associated lymphoma. The polyamine analog may be mitoguazone (MGBG) or a salt thereof or N,N bis(3-ethylaminopropyl)-cis-but-2-ene-1,4-diamine tetrahydrochloride (CG47) or a salt thereof.